Today: January 17, 2019, 5:18 am

WellSky and Digi-Trax Partner to Power Safer and More Efficient Cellular Therapy Management 2018-10-11 01:16:01

Collaboration Provides Clients with Seamless Compliance, Processing, and Labeling

WellSky and Digi-Trax Partner to Power Safer and More Efficient Cellular Therapy Management

for WellSky
Virginia Anderson, 602-885-2000

WellSky, a leading health and community care technology company backed by TPG Capital, and Digi-Trax Corporation, a global leader in compliance labeling solutions, have formed an exclusive partnership. As partners, WellSky and Digi-Trax are combining efforts to seamlessly integrate cellular therapy compliance labeling and cellular therapy management for clinical laboratory, stem cell transplant, and regenerative medicine clients in Australia — one of the world’s rapidly growing markets for cellular and regenerative therapies. The companies have tightly integrated their processes, which enables facilities to reduce errors that could impact life-saving treatments and therapeutic stem cell processing.

WellSky and Digi-Trax deliver integrated services in international markets, including Australia, and in the United States. Outside the U.S., WellSky Biotherapies Lab technology is the preferred cellular laboratory system for Digi-Trax’s HemaTrax®-CT system — an ISBT 128 labeling software and hardware for cellular therapy — that offers end-to-end services to safely and efficiently manage donor, clinician, product, and recipient data all in one place with ISBT 128-compliant labeling on demand.

“In addition to our complementary technologies, WellSky and Digi-Trax also share a deep commitment to providing the best possible solutions to cell therapy providers around the world,” said John Kling, Senior Executive Vice President at Digi-Trax. “With decades of experience in cell therapy solutions, Digi-Trax has a unique understanding of our clients’ needs and a proven track record of delivering the right solutions to meet their needs.”

“WellSky is dedicated to enabling our clients with the highest quality software and services they need to provide vital patient care. We saw Digi-Trax’s leadership in the cellular therapy labeling space and developed a partnership to help our clients ensure accurate labeling that contributes to patient safety,” said Bill Miller, CEO of WellSky. “Optimizing cell therapy workflows while also ensuring compliance is a task we take seriously, and we are committed to finding innovative and collaborative ways to help cell therapy providers succeed operationally and fiscally, and above all, deliver better, safer patient care.”

To learn more, join our webinar on Wednesday, Nov. 7 at 9 a.m. GMT+10 (Tuesday, Nov. 6 at 5 p.m. U.S. CST). Register here.

About WellSky

WellSky is a technology company advancing human wellness worldwide. Our software and professional services address the continuum of health and social care — helping businesses, organizations, and communities solve tough challenges, improve collaboration for growth, and achieve better outcomes through predictive insights that only WellSky solutions can provide. A portfolio company of TPG Capital, WellSky serves more than 10,000 customer sites around the world — including the largest hospital systems, blood banks and labs, home health and hospice franchises, government agencies, and human services organizations. Informed by more than 30 years of providing software and expertise, WellSky anticipates providers’ needs and innovates relentlessly to help people thrive. Our purpose is to empower care heroes with technology for good, so that together, we can realize care’s potential and maintain a healthy, flourishing world. For more information, visit

About Digi-Trax

Digi-Trax has been providing blood banks, transfusion services, laboratories, and cellular therapy facilities with complete label system solutions for more than 25 years. Digi-Trax offers hardware, software, accessories, labels and total technical support and service. Providing consultation since the first ISBT 128 Task Force, Digi-Trax has been instrumental in the development of ISBT 128 standards for cellular therapy. For more information, visit

About TPG

TPG is a leading global alternative asset firm founded in 1992 with more than $84 billion of assets under management and offices in Austin, Beijing, Boston, Dallas, Fort Worth, Hong Kong, Houston, London, Luxembourg, Melbourne, Moscow, Mumbai, New York, San Francisco, Seoul, and Singapore. TPG’s investment platforms are across a wide range of asset classes, including private equity, growth venture, real estate, credit, and public equity. TPG aims to build dynamic products and options for its investors while also instituting discipline and operational excellence across the investment strategy and performance of its portfolio. For more information, visit

.@WellSkyHealth and @Digi_Trax form partnership to make cellular therapy compliance labeling and cellular therapy management even safer and more efficient.

Press Information

Published by
Hossam Abdel-Kader
+43 1 9582319

# 1001 Words
Related Articles
More From The Author
Planet Broadcasting Selects Triton Digital to Deliver [..]
Triton Digital : Through this partnership, Planet Broadcasting will utilize Triton’s robust audio streaming network to deliver [..]
SDRL - Makes mandatory offer to purchase [..]
Hamilton, Bermuda, October 10, 2018 - Seadrill Limited ("Seadrill" or the "Company") announces that it [..]
Third Quarter 2018 Results Conference Call
AURORA, Ontario, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA)                 THIRD QUARTER [..]
A.M. Best Affirms Credit Ratings of Aseguradora [..]
A.M. Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” of [..]
DMV.ORG Named Among Top U.S. Company Cultures, [..]
Encinitas, CA, Oct. 10, 2018 (GLOBE NEWSWIRE) -- DMV.ORG, the nation's largest independent resource for DMV-related information and [..]
More From Business
3,300+ Finance, Business Leaders Join Asian Financial [..]
HONG KONG, Jan 16, 2019 - (ACN Newswire) - More than 3,300 financial policymakers, financial elites and business leaders attended [..]
The Executive Talk: Chememan PCL (SET:CMAN)
BANGKOK, Jan 15, 2019 - (ACN Newswire) - Chememan PCL (SET:CMAN) Chief Executive Officer, Mr. Adisak Lowjun discusses the company's [..]
Sapphire's Subsidiary Awarded EPC Contract of RMB [..]
SINGAPORE, Jan 15, 2019 - (ACN Newswire) - SGX Mainboard-listed Sapphire Corporation Limited ("Sapphire", and together [..]
Hong Kong Investment Promotion chief visits London [..]
HONG KONG, Jan 14, 2019 - (ACN Newswire) - The Director-General of Investment Promotion of the Hong Kong Special Administrative [..]
Wildfire Design & Build Receives 2018 Best [..]
NAPA December 13, 2018 -- Wildfire Design & Build has been selected for the 2018 Best of Napa Award in [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.